Real-World Evidence & Data Analytics; Patient-Centered Outcomes
PhD, MS (Pharmacy Administration), BPharmacy
Bethesda, United States
Namita Joshi is an Associate Director in the Patient-Centered Outcomes and Real-World Evidence & Data Analytics Centers of Excellence with Pharmerit International in the Bethesda, MD office. Her experience includes analyzing patient reported outcomes and health economics data in clinical trials, working on preference studies including time trade-off, discrete choice experiments, and utilizing commercially and publicly available datasets to analyze health-related quality of life information. She has worked across several therapeutic areas including multiple sclerosis, acute myeloid leukemia, depression, cancer, arthritis and hemophilia among others.
She has executed projects related to patient reported outcomes (PROs) and real world evidence/data analytics (RWE/DA). She is particularly involved with projects related to PRO including analyzing health-related quality of life data in clinical trials and eliciting preferences using time trade-off and discrete choice experiment studies. She is also involved in RWE/DA team where she has worked on studies related to disease burden, health care resource utilization, disease incidence/prevalence, adherence/persistence with treatments using public and commercial claims databases. She has also worked on economic models, chart reviews, and systematic/strategic literature reviews. Her dissertation project titled ‘health utility assessment among caregivers of individuals with multiple sclerosis (MS)’ entailed assessment of psychometric properties of a health utility instrument, identification of predictors of health utility using structural equation modeling, and comparison of performance of health utility instruments in a sample of MS caregivers in the US. She holds a Bachelor in Pharmacy degree from New Delhi, India. She received a Master of Science degree in Pharmacy Administration, and a Doctor of Philosophy degree in Pharmaceutical Sciences with an emphasis on Health Economics and Outcomes Research (HEOR) and Pharmaceutical Marketing from the University of Mississippi.